Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice.

cholesterol fat absorption fibrosis liver triglyceride

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2020
Historique:
received: 08 11 2019
accepted: 10 02 2020
entrez: 12 3 2020
pubmed: 12 3 2020
medline: 12 3 2020
Statut: epublish

Résumé

Non-alcoholic fatty liver disease (NAFLD) is a major growing worldwide health problem. We previously reported that interruption of the enterohepatic circulation of bile acids using a non-absorbable apical sodium-dependent bile acid transporter inhibitor (ASBTi; SC-435) reduced the development of NAFLD in high fat diet fed mice. However, the ability of ASBTi treatment to impact the progression of NAFLD to non-alcoholic steatohepatitis (NASH) and fibrosis in a diet-induced mouse model remains untested. In the current study, we assessed whether ASBTi treatment is hepatoprotective in the choline-deficient, L-amino acid-defined (CDAA) diet model of NASH-induced fibrosis.

Identifiants

pubmed: 32158763
doi: 10.3389/fmed.2020.00060
pmc: PMC7052288
doi:

Types de publication

Journal Article

Langues

eng

Pagination

60

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK047987
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK056239
Pays : United States
Organisme : NIDDK NIH HHS
ID : R29 DK047987
Pays : United States

Informations de copyright

Copyright © 2020 Rao, Peppel, Gumber, Karpen and Dawson.

Références

Curr Opin Gastroenterol. 2012 Mar;28(2):159-65
pubmed: 22134222
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3891-6
pubmed: 18292224
PLoS One. 2019 Jun 24;14(6):e0218459
pubmed: 31233523
Metabolism. 1982 May;31(5):438-44
pubmed: 7078426
J Hepatol. 2004 Jan;40(1):47-51
pubmed: 14672613
Am J Physiol Gastrointest Liver Physiol. 2013 Nov;305(9):G620-7
pubmed: 24008359
Sci Transl Med. 2016 Sep 21;8(357):357ra122
pubmed: 27655848
J Lipid Res. 1978 Nov;19(8):1068-70
pubmed: 731127
Dig Liver Dis. 2005 May;37(5):349-56
pubmed: 15843085
Toxicol Appl Pharmacol. 2013 May 1;268(3):264-77
pubmed: 23481610
Gastroenterology. 2017 May;152(7):1679-1694.e3
pubmed: 28214524
J Hepatol. 2018 Aug;69(2):385-395
pubmed: 29572095
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Gastroenterology. 2004 Jul;127(1):139-44
pubmed: 15236180
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
Gastroenterology. 2010 Jul;139(1):323-34.e7
pubmed: 20347818
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):929-942
pubmed: 29746920
PLoS One. 2011;6(5):e20502
pubmed: 21655218
J Hepatol. 1995 Jun;22(6):696-9
pubmed: 7560864
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):943-953
pubmed: 29990551
J Lipid Res. 2019 Sep;60(9):1562-1572
pubmed: 31324653
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):895-911
pubmed: 29782919
JCI Insight. 2018 Apr 19;3(8):
pubmed: 29669937
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
Sci Rep. 2017 Mar 22;7(1):306
pubmed: 28331225
Dig Dis Sci. 2019 May;64(5):1238-1256
pubmed: 30511198
Am J Physiol Gastrointest Liver Physiol. 2008 Feb;294(2):G540-7
pubmed: 18079281
Am J Clin Nutr. 2012 Apr;95(4):892-900
pubmed: 22338037
J Hepatol. 2018 Oct;69(4):896-904
pubmed: 29886156
Dig Dis. 2015;33(3):382-7
pubmed: 26045273
Gut. 2006 Apr;55(4):569-78
pubmed: 16531536
J Nutr Biochem. 2015 Oct;26(10):1077-83
pubmed: 26092371
Gut Microbes. 2016;7(1):22-39
pubmed: 26939849
J Clin Invest. 2004 May;113(10):1408-18
pubmed: 15146238
Cell Metab. 2016 Jul 12;24(1):41-50
pubmed: 27320064
Chem Pharm Bull (Tokyo). 2019;67(4):333-340
pubmed: 30930437
Nature. 2012 Sep 13;489(7415):242-9
pubmed: 22972297
Mitochondrion. 2008 Dec;8(5-6):367-76
pubmed: 18765303
Hepatology. 2018 Dec;68(6):2182-2196
pubmed: 29907965
J Lipid Res. 2011 Nov;52(11):1984-94
pubmed: 21840868
FASEB J. 2010 Jan;24(1):184-95
pubmed: 19752176
PLoS One. 2015 May 27;10(5):e0127991
pubmed: 26017539
J Pathol. 2017 Jan;241(1):36-44
pubmed: 27757953
Int J Cardiol. 2017 Jan 15;227:850-857
pubmed: 28029410
Dig Dis Sci. 2017 Feb;62(2):396-406
pubmed: 27913996
J Hepatol. 2012 Nov;57(5):1061-8
pubmed: 22750465
Liver Int. 2015 Sep;35(9):2129-38
pubmed: 25646700
J Lipid Res. 2020 Jan;61(1):54-69
pubmed: 31645370
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
Gastroenterology. 2013 Sep;145(3):574-82.e1
pubmed: 23727264
J Nutr Sci Vitaminol (Tokyo). 1982 Apr;28(2):139-47
pubmed: 7119905
J Nutr Biochem. 2001 Jun;12(6):330-337
pubmed: 11516636
J Lipid Res. 2008 Jun;49(6):1187-94
pubmed: 18204095
Sci Rep. 2017 Jun 14;7(1):3491
pubmed: 28615649
Lancet. 2015 Mar 14;385(9972):956-65
pubmed: 25468160
PLoS One. 2011;6(9):e24084
pubmed: 21909411
J Biol Chem. 2003 Sep 5;278(36):33920-7
pubmed: 12819193

Auteurs

Anuradha Rao (A)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Ivo P van de Peppel (IP)

Section of Molecular Metabolism and Nutrition, Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.

Sanjeev Gumber (S)

Division of Pathology, Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States.

Saul J Karpen (SJ)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Paul A Dawson (PA)

Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.

Classifications MeSH